Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “parvovirus”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,297 records · Page 72Linked to original sources

Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1.

A normal strain of human foreskin fibroblasts, two SV40-transformed derivatives with finite and infinite life spans, and an established line of SV40-transformed newborn human kidney cells are compared for their susceptibility to infection with parvovirus H-1. H-1 inocula, which do not detectably alter the growth of normal cells, cause a progressive degeneration of all three SV40-transformed cultures. The resistance of normal cells is not a membrane phenomenon since they adsorb and take up H-1 as efficiently as the transformants. Moreover, the fraction of infected cells supporting the synthesis and nuclear migration of H-1 proteins is similar in normal and SV40-transformed cultures. On the other hand, the enhanced H-1 sensitivity of transformed cells correlates with a 5- to 30-fold increase in their accumulation of newly synthesized parvoviral DNA, as compared with normal cultures. This stimulation of H-1 DNA replication is most pronounced for the amplification of duplex replicative forms, although the conversion of parental single-stranded DNA to replicative forms is also enhanced to a smaller extent. In addition, SV40-transformed cells support productive H-1 infection and release a burst of infectious virus, whereas no H-1 production can be detected in the normal cell strain. The latter difference was confirmed for another series of 7 normal and 16 SV40-transformed strains of human skin fibroblasts. Altogether, these results indicate that intracellular limitations on H-1 DNA replication are associated with the abortive nature of the parvoviral life cycle in normal human fibroblasts and are overcome after SV40 transformation, resulting in the selective killing of the transformants. This observation raises the possibility that oncolysis might contribute to the oncosuppressive activity displayed by parvoviruses in vivo.

Cell Survival↗

Bacterial myocarditis secondary to parvovirus enteritis in a puppy.

A purulent bacterial myocarditis, secondary to parvovirus enteritis was diagnosed in a 3-month-old St Bernard puppy. The clinical course was of 2 days duration and was characterized by pyrexia, severe vomition, haemorrhagic diarrhoea and dehydration. Post mortem examination revealed a haemorrhagic enteritis and multifocal purulent myocarditis. Histopathological examination proved that the latter was of bacterial origin. It is postulated that this resulted from a bacteraemia secondary to the intestinal lesions caused by parvovirus infection.

Animals↗

Study of the efficacy of an inactivated virus vaccine against porcine parvovirus.

The efficacy of an inactivated virus vaccine against porcine parvovirus has been studied by immunizing 4 sows during pregnancy. A parvovirus virulent strain has been inoculated to these sows and to two other unvaccinated sows used as controls. The infection was performed between the 52nd and the 57th day of gestation. In the litters born from the vaccinated sows, 82% of the piglets were alive and normal. Neither PPV antibodies nor antigen could be revealed in the stillborn fetuses born from the 4 vaccinated sows. Reversely, only 9.5% of the piglets born from the 2 unvaccinated sows were alive at birth, although they were probably infected during pregnancy. In total, 86% of fetuses in these 2 litters were mummified. A field study allowed to show that the double vaccination antibodies induced, persisted with constant titers for, at least, 13 months. Moreover, the reproductive performance of 413 gilts, vaccinated twice before mating, were not affected by this treatment.

Animals↗

Hormonal changes in sows after induced porcine parvovirus infection in early pregnancy.

Hormonal changes, lesions, and virus isolation studies were determined in sows after uterine artery inoculation with porcine parvovirus [( PPV], strain NADL-8) in early pregnancy. Two sows were given PPV on days 14 or 16 and were euthanatized and necropsied on day 35 after twice daily plasma collection for hormone measurement. Parvovirus was given to 4 sows on day 14 and to 4 sows on day 21 with 5 times daily plasma samples collected for 1 week. Sows were examined on days 21 and 28, respectively. Four control sows in each group on days 14 and 21 were given a placebo injection and were similarly studied. All embryos in all but 1 sow given PPV were in various stages of resorption at necropsy. Normal embryos were present in all control sows. Estrone sulfate values increased logarithmically, progesterone values remained stable, and concentrations of 13, 14-dihydro-15-keto-prostaglandin (PG) F2 alpha (PGFM), a PGF2 alpha metabolite, were less than 200 ng/ml for sows given a placebo. In contrast, sows with resorbing embryos did not have an increase in estrone sulfate values. A decrease in plasma progesterone values occurred in 9 of 10 sows inoculated with PPV; this decrease was accompanied by greater than or equal to 1 marked increase in PGFM concentrations. Quantitative assessment of the uterus revealed significantly greater cytoplasmic density in endometrial and glandular cell (P less than 0.01), a greater glandular epithelium height (P less than 0.05), and twice the number of glands (P less than 0.05) in control sows, compared with values in sows inoculated with PPV.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

[Restriction analysis of the genome of swine abortion parvovirus and cloning of its PstI-EcoRI fragment].

The cultured pig kidney cells infected by the porcine parvovirus (PPV) produced the virions and viral DNA. The latter was used as a matrix to synthesize the double stranded DNA. The obtained preparation is more homogenic than the natural replicative form and was used for restriction analysis of porcine parvovirus genome and for molecular cloning of its fragment. The isolated recombinant plasmids contained the PstI-EcoRI fragment of PPV DNA, containing 70% of the viral genome. The restriction analysis of replicative PPV DNA isolated from the infected cells has resulted in finding of the replicative form containing a 300 bp deletion in the 5'-region of PPV genome.

Abortion, Veterinary↗

Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro.

B19 parvovirus, the cause of fifth disease and transient aplastic crisis, has been successfully propagated in suspension cultures of human erythroid bone marrow cells obtained from patients with sickle cell disease and stimulated by erythropoietin. B19 inoculation in vitro resulted in a marked decline in identifiable erythroid cells over seven to nine days of incubation. Characteristic giant early erythroid cells were seen on Wright's-Giemsa stain of infected cultures. By in situ hybridization, 30% to 40% of erythroblasts were infected at 48 hours; a similar proportion of cells showed B19 capsid protein by immunofluorescence. B19 DNA was present in erythroblasts but not in the leukocyte fraction of bone marrow. B19 replication, as determined by Southern analysis, and B19 encapsidation, as determined by sensitivity of isolated cell fractions to DNase I, were restricted to the nuclei. B19 DNA was detectable in the nuclei from infected cultures beginning at 18 hours and in the supernatant at 32 hours; B19 genome copy number was estimated at about 25,000 to 30,000/infected cell at 48 hours. Recovery of virus depended on the multiplicity of infection (moi); at low moi, approximately 200x input virus was recovered from total cultures and 50x from the culture supernatants. Virus released into the supernatant was as infectious or more infectious than virus obtained from sera of infected patients. Human erythroid bone marrow culture represents a safe in vitro system for the elucidation of the cellular and molecular biology of the pathogenic B19 parvovirus.

Bone Marrow↗

The ability by different preparations of porcine parvovirus to enhance humoral immunity in swine and guinea pigs.

The capacity of different preparations of inactivated porcine parvovirus to stimulate antibody response was studied. The adjuvants chosen were aluminium hydroxide gel [Al(OH)3, 30-50%], water-in-mineral-oil emulsion (w/Mo, 50%) alone or combined with Al(OH)3, and two synthetic products known as dimethyldioctadecylammoniumbromide (DDA, 0.16%) and an acrylic acid polymer resin (Carbopol 934P, 0.02%) respectively. For each preparation, swine and guinea pigs devoid of antibody to porcine parvovirus were inoculated. Among all the preparations tested, two of them i.e. emulsified Al(OH)3 adsorbed antigen and Carbopol 934P emulsified virus, gave the most significant antibody response in animals, without any difference being noted in the behaviour of the two animal species.

Adjuvants, Immunologic↗

[Isolation of conjugated sera for the immunofluorescence demonstration of swine parvovirus].

High-titer, specific serum against porcine parvovirus was obtained via hyperimmunization of rabbits, with the use of a Bulgarian isolate that had been partially purified after a known, modified technique. A specific, high-titer conjugate was produced for the immunofluorescence diagnosis of porcine parvoviruses. The microscopic observation of the lamellae of cell cultures, treated with the conjugate, revealed the presence of a specific, typically granulated perinuclear (mostly unilaterally) and, in some cases nuclear fluorescence--at negative reaction in the control preparations. Immunofluorescent light was also established in cell cultures infected with the virus at highest dilution. It showed that immunofluorescence microscopy could be employed to demonstrate even the lowest amounts of the virus.

Animals↗

Cultivation of a pig parvovirus in various cell cultures.

The susceptibility of several established cell lines of pig (LLC-PK1 = pig kidney; MPK = minipig kidney; PK15 = pig kidney; ESK = embryonic swine kidney), bovine (EBTr = embryonic bovine trachea), monkey (MA-104 = fetal rhesus monkey kidney) and human (HEL-299 = embryonic human lung) origin to porcine parvovirus was studied. The primary pig kidney cell cultures (pPK) were included in the study as the reference cell system. From the results it appeared that the virus only replicated in cell lines originated from swine. In particular the MPK and ESK cell lines showed a susceptibility similar to that observed for pPK cell cultures. Intranuclear inclusions and plaques were also induced in these cell systems. It appeared therefore that MPK and ESK cell lines both possess all the requirements for use in pig parvovirus studies.

Animals↗

Response of pups to modified-live canine parvovirus component in a combination vaccine.

Twenty-eight pups from a general pet population were vaccinated for canine parvovirus (CPV) with a combination vaccine every 3 weeks until the pups were 11 to 16 weeks old. Canine parvovirus antibody titers were measured by serum neutralization before each vaccination and greater than or equal to 2 weeks after the final vaccination. Eighteen pups that initially were seronegative for CPV seroconverted after 1 to 3 doses of modified-live virus CPV vaccine administered when the pups were between 8 and 16 weeks old; 16 of 18 seroconverted after the 1st dose. Of 10 pups that were seropositive for CPV at initial examination, 7 did not develop protective titers after 3 doses of vaccine, with the last dose given when the pups were 14 to 16 weeks old. Maternally derived antibody was the primary cause of vaccination failure.

Animals↗

[Sensitivity of various cell cultures to the swine parvovirus].

Attempts were made to culture the swine parvovirus under laboratory conditions. A reference strain and a field isolate were used along with steady cell lines of pig kidney PK-15, IBAS-2, and SPEV as well as primary and secondary cell cultures of pig kidney. It was found that the steady cell lines were slightly sensitive or totally unsusceptible to the swine parvovirus. The could serve for its isolation from pathologic material and culturing in laboratory conditions. Both the primary and the secondary cell cultures proved strongly susceptible to the virus, and they could be used for the isolation of filed strains as well as for the laboratory maintenance of the virus. The strains used produced no clearly distinguishable cytopathic effects in the inoculated cell cultures. The morphologic changes that set in following inoculation with higher amounts of the virus could be seen under the light microscope and could be evaluated through cytologic investigations (the presence of intranuclear inclusion bodies). The virus could be most readily demonstrated in the infected cell cultures via the hemagglutination test.

Animals↗

Porcine parvovirus: propagation in microcarrier cell culture and immunogenic evaluation in pregnant gilts.

Porcine parvovirus was propagated in PK-15 cells cultured in roller bottles or on microcarrier beads. After inactivation, the virus was used as antigen in the preparation of vaccines. The immunogenic potency and safety of the vaccines were evaluated in specific pathogen free pregnant gilts and guinea pigs. Experimental challenge tests determined the efficacy of the vaccine in preventing porcine parvovirus transplacental infection. Neither viral antigens nor specific antibodies were detected in fetuses from vaccinated gilts. In contrast, fetal death and, or, mummification occurred when unvaccinated gilts were infected. Both virus and, or, antibodies were also detected in fetuses from these unvaccinated gilts. Serum conversion after vaccination was assayed by microserum neutralisation using guinea pig erythrocytes as cell indicators and by haemagglutination inhibition tests. Viral antigens in fetal tissues were detected using ELISA, the immunobeads technique, the haemagglutination test and by virus isolation.

Animals↗

Sudden death in young dogs with myocarditis caused by parvovirus.

Sudden death of pups in the 4- to 6-week age range has recently been occurring in western Canada as a result of severe, primary, nonsuppurative myocarditis. At necropsy, the prominent macroscopic lesion was pulmonary edema, and microscopically, characteristic intranuclear inclusion bodies were found within cardiac myofibers in association with myocarditis. Ultrastructurally, numerous small particles resembling parvoviruses were found within the intranuclear inclusion bodies, which were positive by direct fluorescent antibody test for canine parvovirus. Of three pups inoculated with homogenate from affected myocardium, one developed lesions resembling canine parvoviral enteritis.

Animals↗

[Serological detection of parvovirus infection in dogs using the hemagglutination inhibition test].

Throughout the year 1982 the parvovirus disease of dogs in the Czechoslovak Socialist Republic was proved by means of haemagglutination-inhibition test (HIT). 317 serum samples of dogs from different localities were examined. The highest spreading of this disease was detected in urban areas where the possibilities of direct and indirect infection were much higher. In 70% of the cases the titres of HI antibodies varied from 256 to 4096. The HIT method is suitable for serological screening of parvovirus disease of dogs.

Animals↗

Suspected parvovirus infection in porcupines.

During a 142-day period, 6 porcupines died or were killed after becoming moribund. Three had severe acute necrotizing enteritis; two had acute necrotizing myocarditis, one with concurrent lymphocytic-plasmacytic enteritis; and one had chronic enteritis. Histologically, the acute necrotizing enteritis was characterized by villous fusion, blunting, and crypt dilatation. Many dilated crypts contained necrotic debris and were lined by flattened enterocytes. Acidophilic intranuclear inclusions were in colonic epithelial cells in one of these animals. The myocardial lesions consisted of degenerating shrunken myofibers, with infiltrating neutrophils and lymphocytes. Myofiber mineralization was evident in one animal. Though the histologic findings were indicative of parvovirus infection, electron microscopic, serologic, and virologic studies failed to demonstrate parvovirus as the etiologic agent.

Alberta↗

Parvovirus contamination of a human type 12 adenovirus strain.

A strain of human type 12 adenovirus was found contaminated with virions 27 nm in diameter. After separation by membrane filtration, adsorption on to and elution from erythrocytes and heat treatment, the contaminant was classified as a parvovirus based on its biological and physico-chemical properties and virion morphology. This parvovirus failed to produce interferon and did not affect the interferon-inducing ability of the adenovirus from which it had been separated.

Adenoviruses, Human↗

Pool and synthesis of phosphoribosylpyrophosphate in rat embryo cells infected with X14 or H-1 parvovirus.

In rat embryo cell cultures infected with X14 or H-1 parvovirus the PRPP pool and the PRPP synthetase activity have been assayed. A radiometric method, prepared by Authors, based on the conversion of [6-14C) orotate to [6-14C) UMP by the mixed enzyme orotate phosphoribosyltransferase and orotidylate decarboxylase and on the separation of UMP by ascending chromatography, has been utilized. The PRPP pool and te PRPP synthetase activity appeared nearly unmodified in the cells infected with X14 or H-1 parvovirus compared to the mock-infected cells. Therefore, the lowered pyrimidine nucleotide synthesis in infected cells, shown in previous studies, may depend, rather than on the diminished PRPP pool, on the lower PRPP utilization; in fact, some inhibition by metabolites, that may be removed by added PRPP, might occur in the infected cells.

Animals↗

Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines.

Inactivated canine parvovirus (CPV) and inactivated feline panleukopenia virus (FPV) vaccines were evaluated in dogs. Maximal serologic response occurred within 1-2 weeks after vaccination. Antibody titers then declined rapidly to low levels that persisted at least 20 weeks. Immunity to CPV, defined as complete resistance to infection, was correlated with serum antibody titer and did not persist longer than 6 weeks after vaccination with inactivated virus. However, protection against generalized infection was demonstrated 20 weeks after vaccination. In unvaccinated dogs, viremia and generalized infection occurred after oronasal challenge with virulent CPV. In contrast, viral replication was restricted to the intestinal tract and gut-associated lymphoid tissue of vaccinated dogs. Canine parvovirus was inactivated by formalin, beta-propiolactone (BPL), and binary ethylenimine (BEI) in serum-free media; inactivation kinetics were determined. Formalin resulted in a greater loss of viral HA than either BEI of BPL, and antigenicity was correspondingly reduced.

Animals↗